Oramed Pharmaceuticals Inc Working Capital to Net Assets Ratio
Oramed Pharmaceuticals Inc working capital to net assets ratio. Oramed Pharmaceuticals Inc (ORMP) has a Working Capital to Net Assets ratio of 24.2% as of March 2026. Working capital of $57.59 Million (current assets of $68.15 Million minus current liabilities of $10.56 Million) is measured against net assets of $238.28 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Oramed Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Oramed Pharmaceuticals Inc (2005–2025)
Working capital to net assets ratio of Oramed Pharmaceuticals Inc from 2005 to 2025. This chart shows how Oramed Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 24.2%, reflecting working capital of $57.59 Million against net assets of $238.28 Million USD. See Oramed Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Oramed Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2005–2025)
Oramed Pharmaceuticals Inc working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Oramed Pharmaceuticals Inc from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Oramed Pharmaceuticals Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 57.2% | $114.19 Million | $199.74 Million | $133.27 Million | $19.09 Million | ▼ -37.5 pp |
| 2024 | 94.6% | $137.54 Million | $145.35 Million | $143.22 Million | $5.68 Million | ▲ +27.5 pp |
| 2023 | 67.1% | $109.37 Million | $162.89 Million | $162.58 Million | $53.21 Million | ▼ -33.0 pp |
| 2022 | 100.1% | $151.36 Million | $151.16 Million | $157.11 Million | $5.75 Million | ▲ +24.0 pp |
| 2021 | 76.1% | $88.66 Million | $116.52 Million | $95.34 Million | $6.68 Million | ▼ -33.3 pp |
| 2020 | 109.4% | $35.98 Million | $32.88 Million | $40.51 Million | $4.54 Million | ▼ -35.0 pp |
| 2019 | 144.5% | $28.02 Million | $19.39 Million | $33.32 Million | $5.31 Million | ▲ +59.3 pp |
| 2018 | 85.1% | $26.48 Million | $31.11 Million | $31.04 Million | $4.55 Million | ▲ +6.5 pp |
| 2017 | 78.7% | $15.13 Million | $19.24 Million | $20.30 Million | $5.17 Million | ▼ -26.8 pp |
| 2016 | 105.4% | $27.61 Million | $26.19 Million | $31.23 Million | $3.62 Million | ▲ +41.4 pp |
| 2015 | 64.0% | $15.88 Million | $24.83 Million | $17.37 Million | $1.49 Million | ▼ -36.1 pp |
| 2014 | 100.1% | $20.80 Million | $20.79 Million | $21.78 Million | $973.00K | ▼ -0.1 pp |
| 2013 | 100.2% | $8.15 Million | $8.13 Million | $8.64 Million | $498.19K | ▼ -22.4 pp |
| 2012 | 122.6% | $4.63 Million | $3.78 Million | $5.28 Million | $644.42K | ▲ +19.4 pp |
| 2011 | 103.2% | $3.84 Million | $3.72 Million | $4.28 Million | $441.29K | ▼ -9.8 pp |
| 2010 | 113.0% | $938.23K | $830.27K | $1.40 Million | $458.58K | ▲ +10.8 pp |
| 2009 | 102.2% | $2.81 Million | $2.75 Million | $3.17 Million | $368.60K | ▲ +4.5 pp |
| 2008 | 97.6% | $4.48 Million | $4.59 Million | $5.40 Million | $913.95K | ▼ -1.0 pp |
| 2007 | 98.6% | $506.00K | $513.00K | $1.93 Million | $1.42 Million | ▼ -1.4 pp |
| 2006 | 100.0% | $-432.72K | $-432.72K | $176.19K | $608.91K | ▲ +0.0 pp |
| 2005 | 100.0% | $-44.81K | $-44.81K | $1.26K | $46.07K | — |